You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastasized

Showing 1 - 25 of 232
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET/CT response evaluation
  • Utrecht, Netherlands
    Roderick van den Bergh
Sep 10, 2022

Metastasized Gastro-Oesophageal Cancer Trial in Toronto (FAZA PET/MRI scan)

Recruiting
  • Metastasized Gastro-Oesophageal Cancer
  • FAZA PET/MRI scan
  • Toronto, Ontario, Canada
    Univeristy Health Network
May 20, 2022

Chemotherapy in Synchronously Metastasized Colorectal Cancer

Completed
  • Gastrointestinal Neoplasm
    • Vienna, Vienna/Austria, Austria
      Clinic Favoriten
    Dec 12, 2021

    Solid Tumor, Adult Trial in Beijing, Shanxi, Shenzhen (ABO2011 Injection)

    Recruiting
    • Solid Tumor, Adult
    • ABO2011 Injection
    • Beijing, China
    • +2 more
    Oct 13, 2023

    Stage IV Uveal Melanoma Trial in Philadelphia (Sir-Spheres®)

    Active, not recruiting
    • Stage IV Uveal Melanoma
    • Sir-Spheres®
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Dec 20, 2022

    Prostate Cancer Trial in Amersfoort, Utrecht (PSMA-PET/CT)

    Recruiting
    • Prostate Cancer
    • PSMA-PET/CT
    • Amersfoort, Netherlands
    • +2 more
    Dec 3, 2021

    Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

    Recruiting
    • Malignant Melanoma
    • Pembrolizumab Injection [Keytruda]
    • +6 more
    • Herlev, Hovedstaden, Denmark
    • +2 more
    Sep 16, 2022

    Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

    Recruiting
    • Ewing Sarcoma
    • +2 more
    • Peptide vaccine IPX
    • Frankfurt am Main, Germany
    • +2 more
    Oct 18, 2023

    Synchronous Metastasized Breast Cancer, Circulating Tumor Cells Trial in Austria (Surgery, Surgery on Demand)

    Active, not recruiting
    • Synchronous Metastasized Breast Cancer
    • Circulating Tumor Cells
    • Surgery
    • Surgery on Demand
    • Guessing, Burgenland, Austria
    • +13 more
    May 24, 2022

    Gut Microbiome Dynamics in Metastasized or Irresectable

    Recruiting
    • Colorectal Cancer Metastatic
    • fecal sample
    • +2 more
    • Assen, Netherlands
    • +9 more
    Jan 4, 2022

    Uveal Melanoma, Metastatic Trial in Leiden (Ipilimumab and nivolumab, Melphalan chemosaturation via percutaneous hepatic

    Recruiting
    • Uveal Melanoma, Metastatic
    • Ipilimumab and nivolumab
    • Melphalan chemosaturation via percutaneous hepatic perfusion
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Apr 8, 2022

    Radiotherapy, Immunology Trial in Ghent (Cyclophosphamide, Stereotactic body radiotherapy)

    Withdrawn
    • Radiotherapy
    • Immunology
    • Ghent, Belgium
      University Hospital - Radiotherapy Department
    Jul 7, 2021

    Metastatic Pancreas Cancer Trial in Amsterdam (Folfirinox)

    Recruiting
    • Metastatic Pancreas Cancer
    • Amsterdam, Noord-Holland, Netherlands
      Academic Medical Center
    May 18, 2021

    Non-study Population of Symptomatic mCRPC Patients Treated With

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Bone Metastases
    • Blood tests
    • Amsterdam, Netherlands
    • +1 more
    Apr 20, 2022

    Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)

    Completed
    • Prostate Cancer Metastatic
    • Metastasis
    • Alkmaar, Netherlands
    • +18 more
    Apr 14, 2022

    Neuroendocrine Tumors Trial in Germany (Octreotide LAR (Long-acting release), Placebo)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • Octreotide LAR (Long-acting release)
    • Placebo
    • Bochum, Germany
    • +9 more
    Mar 16, 2020

    Sarcoma, Melanoma, Epithelial Malignancies Trial run by the NCI (Cyclophosphamide, Allogenic tumor Cell Vaccine (K562),

    Terminated
    • Sarcoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 2, 2020

    Pancreatic Cancer Trial in Amsterdam (gemcitabine and nab paclitaxel)

    Completed
    • Pancreatic Cancer
    • gemcitabine and nab paclitaxel
    • Amsterdam, Netherlands
      Academic Medical Center
    Jan 7, 2020

    Metastatic Cancer, CNS Cancer Trial in Boston (Niraparib)

    Recruiting
    • Metastatic Cancer
    • Central Nervous System Cancer
    • Boston, Massachusetts
    • +2 more
    Jan 28, 2022

    Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)

    Recruiting
    • Glioblastoma Multiforme
    • +3 more
    • Lyon Cedex, France
      Novartis Investigative Site
    Aug 9, 2022

    IA Lung Adenocarcinoma, Combined Segmentectomy Trial in Fuzhou (Patients receive subsegmentectomy)

    Active, not recruiting
    • IA Lung Adenocarcinoma
    • Combined Segmentectomy
    • Patients receive subsegmentectomy
    • Fuzhou, China
      Fujian Medical University Union Hospital
    Aug 2, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

    Recruiting
    • Pancreatic Neuroendocrine Tumor
    • peptide receptor radionuclide therapy with Y-90-DOTATOC
    • Milano, Italy
    • +1 more
    Sep 30, 2022

    Microbiome in Colorectal Cancer Onset and Progression

    Terminated
    • Colorectal Cancer
    • +4 more
      • Bellevue, Washington
        Washington Gastroenterology
      Dec 23, 2022

      Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

      Not yet recruiting
      • Oral Squamous Cell Carcinoma
      • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
      • (no location specified)
      Nov 11, 2023